Harrow (HROW) vs OPKO Health (OPK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
OPKO Health (OPK) has outperformed Harrow (HROW) over the past year, losing 9.7% versus a loss of 26.9%. Over five years, HROW leads with a +209.6% price change compared with -62.6% for OPK. Harrow is the larger company by market cap ($1.15 billion vs $1.04 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HROW | OPK |
|---|---|---|
| Share price | $30.62 | $1.39 |
| Market cap | $1.15B | $1.04B |
| 1-day change | +0.89% | -4.79% |
| YTD return | -37.51% | +10.32% |
| 1-year return | -26.92% | -9.74% |
| 5-year return | +209.61% | -62.63% |
| Forward P/E | 11.04 | — |
| EPS (TTM) | $-0.99 | $-0.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $54.85 | $1.75 |
| 52-week low | $28.54 | $0.98 |
| Distance from 52-week high | -44.18% | -20.57% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +112.28% | +215.11% |
| Average volume | 552.72K | 3.37M |
| Shares outstanding | 37.49M | 746.33M |
| Employees | 373 | 2,275 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OPK has outperformed HROW by 17.2 percentage points over the past year.
About Harrow
HROW stock →Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments.
Health Care · Biotechnology: Pharmaceutical Preparations · 373 employees
About OPKO Health
OPK stock →OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.
Health Care · Biotechnology: Pharmaceutical Preparations · 2,275 employees
HROW vs OPK FAQ
Which is bigger, Harrow or OPKO Health?
Harrow (HROW) is larger, with a market capitalization of $1.15B compared with $1.04B for OPKO Health (OPK).
Which stock has performed better over the past year, HROW or OPK?
OPK returned -9.74% over the past 12 months, compared with -26.92% for HROW (price return, excluding dividends). Past performance does not predict future results.
Are Harrow and OPKO Health in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.